全文获取类型
收费全文 | 4857047篇 |
免费 | 383103篇 |
国内免费 | 17237篇 |
专业分类
耳鼻咽喉 | 68415篇 |
儿科学 | 157603篇 |
妇产科学 | 131298篇 |
基础医学 | 730727篇 |
口腔科学 | 136610篇 |
临床医学 | 450226篇 |
内科学 | 876151篇 |
皮肤病学 | 118158篇 |
神经病学 | 401216篇 |
特种医学 | 187652篇 |
外国民族医学 | 825篇 |
外科学 | 731792篇 |
综合类 | 138250篇 |
现状与发展 | 23篇 |
一般理论 | 2819篇 |
预防医学 | 412257篇 |
眼科学 | 115164篇 |
药学 | 345120篇 |
25篇 | |
中国医学 | 13167篇 |
肿瘤学 | 239889篇 |
出版年
2021年 | 52738篇 |
2019年 | 60827篇 |
2018年 | 78041篇 |
2017年 | 59446篇 |
2016年 | 66002篇 |
2015年 | 78544篇 |
2014年 | 113817篇 |
2013年 | 180288篇 |
2012年 | 148549篇 |
2011年 | 158240篇 |
2010年 | 135370篇 |
2009年 | 133633篇 |
2008年 | 141629篇 |
2007年 | 151765篇 |
2006年 | 158664篇 |
2005年 | 152853篇 |
2004年 | 151729篇 |
2003年 | 140466篇 |
2002年 | 128618篇 |
2001年 | 179475篇 |
2000年 | 175499篇 |
1999年 | 157818篇 |
1998年 | 68597篇 |
1997年 | 63592篇 |
1996年 | 61542篇 |
1995年 | 62258篇 |
1994年 | 56455篇 |
1993年 | 52316篇 |
1992年 | 117348篇 |
1991年 | 114350篇 |
1990年 | 110116篇 |
1989年 | 106691篇 |
1988年 | 98528篇 |
1987年 | 96768篇 |
1986年 | 91662篇 |
1985年 | 89725篇 |
1984年 | 73307篇 |
1983年 | 64879篇 |
1982年 | 49846篇 |
1981年 | 46341篇 |
1980年 | 43402篇 |
1979年 | 64774篇 |
1978年 | 51405篇 |
1977年 | 44581篇 |
1976年 | 42149篇 |
1975年 | 42659篇 |
1974年 | 48040篇 |
1973年 | 46277篇 |
1972年 | 43508篇 |
1971年 | 40603篇 |
排序方式: 共有10000条查询结果,搜索用时 28 毫秒
1.
2.
3.
Espersen Caroline Modin Daniel Hoffmann Søren Hagemann Christoffer A. Hagemann Rikke A. Olsen Flemming J. Fritz-Hansen Thomas Platz Elke Møgelvang Rasmus Biering-Sørensen Tor 《The international journal of cardiovascular imaging》2022,38(1):131-140
The International Journal of Cardiovascular Imaging - Global longitudinal strain (GLS) has proven to be a powerful prognostic marker in various patient populations, but the prognostic value of... 相似文献
4.
Rizzo Giuseppe Pietrolucci Maria Elena Capponi Alessandra Mappa Ilenia 《The international journal of cardiovascular imaging》2022,38(5):1017-1019
The International Journal of Cardiovascular Imaging - 相似文献
5.
Marco N. Iannone Stefano Stucchi Elia A. Turolla Chiara Beretta Samuele Ciceri Clizia Chinello Lisa Pagani Sergio Todde Patrizia Ferraboschi 《Journal of labelled compounds & radiopharmaceuticals》2022,65(3):48-62
In the last decade, the development of new radiopharmaceuticals for the imaging and therapy of prostate cancer has been a highly active and important area of research, especially focusing on the prostate-specific membrane antigen (PSMA), an antigen which is upregulated in prostate, as well as in other tumor cells. A large variety of PSMA ligands have been radiolabeled, to date. Among the various derivatives, PSMA-617 resulted to be one of the most interesting in terms of interaction with the antigen and clinical properties, and its lutetium-177 labeled version has recently been approved by regulatory agencies for therapeutic purposes. For this reasons, the radiolabeling with fluorine-18 of a PSMA-617 derivative might be of interest. Beside other methodologies to radiolabel macromolecules with fluorine-18, the “click-chemistry” approach resulted to be very useful, and the copper-catalyzed azide-alkyne cycloaddition (CuAAC) is considered one of most efficient and reliable. This paper proposes the synthesis of a suitable precursor for the radiolabeling with fluorine-18 of a new PSMA-617 derivative. The whole radiosynthetic procedure has been fully automated, and the final product, which proved to be stable in plasma, has been obtained with radiochemical yield and purity suitable for subsequent preclinical studies. 相似文献
6.
7.
8.
Alicia C. McDonald PhD MPH Jeremy Gernand PhD Nathaniel R. Geyer DrPH Hongke Wu MD MPH Yanxu Yang MPH Ming Wang PhD 《Cancer》2022,128(9):1832-1839
9.
10.
Anna Maria Spera 《World Journal of Virology》2022,11(5):275-282
With a 5.3% of the global population involved, hepatitis B virus (HBV) is a major public health challenge requiring an urgent response. After a possible acute phase, the natural history of HBV infection can progress in chronicity. Patients with overt or occult HBV infection can undergo HBV reactivation (HBVr) in course of immunosuppressive treatments that, apart from oncological and hem-atological diseases, are also used in rheumatologic, gastrointestinal, neurological and dermatological settings, as well as to treat severe acute respiratory syndrome coronavirus 2 infection. The risk of HBV reactivation is related to the immune status of the patient and the baseline HBV infection condition. The aim of the present paper is to investigate the risk of HBVr in those not oncological settings in order to suggest strategies for preventing and treating this occurrence. The main studies about HBVr for patients with occult hepatitis B infection and chronic HBV infection affected by non-oncologic diseases eligible for immunosuppressive treatment have been analyzed. The occurrence of this challenging event can be reduced screening the population eligible for immunosuppressant to assess the best strategies according to any virological status. Further prospective studies are needed to increase data on the risk of HBVr related to newer immunomodulant agents employed in non-oncological setting. 相似文献